Evidence for Hydroxocobalamin in Cyanide Toxicity Caused by Smoke Inhalation: An Updated Systematic Review. (2025)

Peer-Reviewed Study · Jin WY, Huang DC, Guo J, Jin D, Ying AF · December 31, 2025

Jin WY et al., 2025-12-31: Updated systematic review stating that hydroxocobalamin, not methylene blue, is the first-line treatment for confirmed cyanide poisoning.

Hydroxocobalamin is the first-line treatment for confirmed cyanide poisoning.

Jin WY et al., 2025-12-31: Updated systematic review stating that hydroxocobalamin, not methylene blue, is the first-line treatment for confirmed cyanide poisoning. C9. Study type: systematic review (PRISMA) of hydroxocobalamin in smoke-inhalation cyanide toxicity; Taizhou Hospital of Zhejiang Province, China. No methylene blue arm. The quoted sentence is the review's own statement of current first-line therapy, which is the plainest answer to whether methylene blue is currently recommended for cyanide poisoning. Funders/conflicts not stated in the abstract. Emerg Med Int 2025;2025:1779752. Study type: review.